GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Cyclically Adjusted PS Ratio

Camurus AB (FRA:7CA) Cyclically Adjusted PS Ratio : 54.30 (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Cyclically Adjusted PS Ratio?

As of today (2024-05-16), Camurus AB's current share price is €47.78. Camurus AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €0.88. Camurus AB's Cyclically Adjusted PS Ratio for today is 54.30.

The historical rank and industry rank for Camurus AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:7CA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 46.7   Med: 53.4   Max: 62.43
Current: 56.86

During the past years, Camurus AB's highest Cyclically Adjusted PS Ratio was 62.43. The lowest was 46.70. And the median was 53.40.

FRA:7CA's Cyclically Adjusted PS Ratio is ranked worse than
93.55% of 512 companies
in the Biotechnology industry
Industry Median: 5.535 vs FRA:7CA: 56.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Camurus AB's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.583. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.88 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Camurus AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Camurus AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Cyclically Adjusted PS Ratio Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 57.15

Camurus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 57.15 51.53

Competitive Comparison of Camurus AB's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Camurus AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Camurus AB's Cyclically Adjusted PS Ratio falls into.



Camurus AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Camurus AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=47.78/0.88
=54.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Camurus AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.583/132.2054*132.2054
=0.583

Current CPI (Mar. 2024) = 132.2054.

Camurus AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.000 100.541 0.000
201409 0.090 100.161 0.119
201412 0.376 100.225 0.496
201503 0.230 99.950 0.304
201506 0.060 99.995 0.079
201509 0.097 100.228 0.128
201512 0.096 100.276 0.127
201603 0.054 100.751 0.071
201606 0.068 101.019 0.089
201609 0.078 101.138 0.102
201612 0.093 102.022 0.121
201703 0.044 102.022 0.057
201706 0.047 102.752 0.060
201709 0.031 103.279 0.040
201712 0.013 103.793 0.017
201803 0.038 103.962 0.048
201806 0.018 104.875 0.023
201809 0.047 105.679 0.059
201812 0.015 105.912 0.019
201903 0.041 105.886 0.051
201906 0.021 106.742 0.026
201909 0.075 107.214 0.092
201912 0.066 107.766 0.081
202003 0.085 106.563 0.105
202006 0.144 107.498 0.177
202009 0.173 107.635 0.212
202012 0.186 108.296 0.227
202103 0.222 108.360 0.271
202106 0.244 108.928 0.296
202109 0.267 110.338 0.320
202112 0.314 112.486 0.369
202203 0.369 114.825 0.425
202206 0.375 118.384 0.419
202209 0.387 122.296 0.418
202212 0.423 126.365 0.443
202303 0.440 127.042 0.458
202306 1.005 129.407 1.027
202309 0.565 130.224 0.574
202312 0.583 131.912 0.584
202403 0.583 132.205 0.583

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Camurus AB  (FRA:7CA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Camurus AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Camurus AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (FRA:7CA) Business Description

Industry
Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines